Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2023) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Drugs | journal | 2.352 Q1 | 188 | 138 | 490 | 9241 | 4984 | 465 | 10.27 | 66.96 |  |
| 2 | Journal of Biomedical Science | journal | 2.606 Q1 | 110 | 96 | 288 | 10080 | 2990 | 288 | 8.54 | 105.00 | |
| 3 | Acta Pharmacologica Sinica | journal | 1.882 Q1 | 117 | 217 | 643 | 13284 | 5055 | 633 | 7.19 | 61.22 | |
| 4 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | |
| 5 | CNS Drugs | journal | 1.616 Q1 | 129 | 74 | 264 | 5881 | 1631 | 253 | 6.14 | 79.47 | |
| 6 | npj Breast Cancer | journal | 2.275 Q1 | 46 | 95 | 346 | 4112 | 2003 | 339 | 5.65 | 43.28 | |
| 7 | BioDrugs | journal | 1.796 Q1 | 79 | 62 | 166 | 5182 | 1068 | 161 | 5.59 | 83.58 | |
| 8 | Molecular Therapy - Oncolytics | journal | 1.494 Q1 | 42 | 97 | 488 | 5554 | 2595 | 478 | 5.35 | 57.26 | |
| 9 | CNS Neuroscience and Therapeutics | journal | 1.473 Q1 | 91 | 418 | 491 | 24328 | 2516 | 434 | 4.95 | 58.20 | |
| 10 | Antimicrobial Resistance and Infection Control | journal | 1.256 Q1 | 66 | 143 | 522 | 6549 | 2764 | 509 | 4.86 | 45.80 | |
| 11 | Expert Opinion on Investigational Drugs | journal | 1.414 Q1 | 117 | 108 | 354 | 8144 | 1698 | 322 | 4.77 | 75.41 | |
| 12 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | |
| 13 | Journal of Psychopharmacology | journal | 1.366 Q1 | 135 | 125 | 424 | 8028 | 1891 | 397 | 4.57 | 64.22 | |
| 14 | Advanced Therapeutics | journal | 1.063 Q1 | 39 | 159 | 324 | 12890 | 1482 | 319 | 4.31 | 81.07 | |
| 15 | Clinical Pharmacokinetics | journal | 1.125 Q1 | 184 | 125 | 363 | 5322 | 1577 | 335 | 4.09 | 42.58 | |
| 16 | Cochrane Database of Systematic Reviews | journal | 1.408 Q1 | 327 | 536 | 2407 | 79418 | 10906 | 2382 | 4.03 | 148.17 | |
| 17 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 1.507 Q1 | 40 | 94 | 329 | 2657 | 1095 | 203 | 3.62 | 28.27 | |
| 18 | Therapeutic Advances in Respiratory Disease | journal | 1.179 Q1 | 50 | 78 | 206 | 3651 | 791 | 194 | 3.55 | 46.81 | |
| 19 | Expert Review of Clinical Pharmacology | journal | 0.990 Q1 | 60 | 112 | 384 | 8775 | 1441 | 357 | 3.53 | 78.35 | |
| 20 | Paediatric Drugs | journal | 1.017 Q1 | 70 | 56 | 163 | 3652 | 629 | 158 | 3.52 | 65.21 | |
| 21 | Rheumatology | journal | 1.721 Q1 | 198 | 675 | 2199 | 18790 | 7802 | 1532 | 3.44 | 27.84 | |
| 22 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | |
| 23 | Journal of Antimicrobial Chemotherapy | journal | 1.271 Q1 | 221 | 417 | 1569 | 13480 | 6161 | 1374 | 3.35 | 32.33 | |
| 24 | Drug Safety | journal | 1.204 Q1 | 140 | 108 | 359 | 4530 | 1291 | 313 | 3.33 | 41.94 | |
| 25 | Orphanet Journal of Rare Diseases | journal | 1.182 Q1 | 136 | 386 | 1277 | 16047 | 4683 | 1226 | 3.33 | 41.57 | |
| 26 | Expert Review of Neurotherapeutics | journal | 0.957 Q1 | 98 | 108 | 322 | 11035 | 1154 | 289 | 3.25 | 102.18 | |
| 27 | Drugs and Aging | journal | 0.894 Q1 | 109 | 86 | 254 | 5801 | 811 | 246 | 3.24 | 67.45 | |
| 28 | Therapeutic Advances in Drug Safety | journal | 1.035 Q1 | 46 | 27 | 103 | 1296 | 396 | 91 | 3.07 | 48.00 | |
| 29 | British Journal of Clinical Pharmacology | journal | 1.046 Q1 | 167 | 409 | 1287 | 16426 | 4049 | 1111 | 3.04 | 40.16 | |
| 30 | Expert Opinion on Drug Safety | journal | 0.905 Q1 | 90 | 165 | 441 | 8337 | 1384 | 401 | 3.03 | 50.53 | |
| 31 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | |
| 32 | Alimentary Pharmacology and Therapeutics | journal | 2.794 Q1 | 207 | 471 | 1573 | 10837 | 5022 | 672 | 2.91 | 23.01 | |
| 33 | Expert Review of Anticancer Therapy | journal | 0.827 Q2 | 85 | 123 | 370 | 8783 | 1034 | 330 | 2.78 | 71.41 | |
| 34 | American Journal of Cardiovascular Drugs | journal | 0.790 Q2 | 60 | 60 | 184 | 2987 | 512 | 174 | 2.66 | 49.78 | |
| 35 | HIV Medicine | journal | 1.052 Q1 | 86 | 151 | 348 | 5203 | 911 | 321 | 2.64 | 34.46 | |
| 36 | Clinical Drug Investigation | journal | 0.680 Q2 | 67 | 96 | 332 | 2966 | 860 | 305 | 2.63 | 30.90 | |
| 37 | Expert Opinion on Emerging Drugs | journal | 0.881 Q1 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | |
| 38 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | |
| 39 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | |
| 40 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q3 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | |
| 41 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 110 | 288 | 7063 | 732 | 272 | 2.48 | 64.21 | |
| 42 | Therapeutic Advances in Cardiovascular Disease | journal | 0.553 Q2 | 41 | 17 | 40 | 1230 | 95 | 37 | 2.48 | 72.35 | |
| 43 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | |
| 44 | Expert Opinion on Pharmacotherapy | journal | 0.687 Q2 | 93 | 206 | 669 | 15644 | 1640 | 573 | 2.15 | 75.94 | |
| 45 | HIV Research and Clinical Practice | journal | 0.616 Q2 | 54 | 14 | 52 | 571 | 97 | 52 | 2.15 | 40.79 | |
| 46 | Pharmacoepidemiology and Drug Safety | journal | 1.106 Q1 | 109 | 149 | 547 | 5012 | 1367 | 506 | 2.12 | 33.64 | |
| 47 | Human Psychopharmacology | journal | 0.541 Q3 | 86 | 23 | 117 | 1225 | 246 | 116 | 1.98 | 53.26 | |
| 48 | Trials | journal | 0.812 Q2 | 98 | 802 | 2956 | 30481 | 6129 | 2785 | 1.93 | 38.01 | |
| 49 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q3 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | |
| 50 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.569 Q2 | 81 | 55 | 756 | 2389 | 1526 | 695 | 1.91 | 43.44 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data